Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CORRESP Jul 13, 2020
UPLOAD Jul 10, 2020
SC 13D/A Jul 1, 2020
4 Jun 30, 2020 PRIMARY DOCUMENT
4 Jun 30, 2020 PRIMARY DOCUMENT
4 Jun 30, 2020 PRIMARY DOCUMENT
SC 13D/A Jun 30, 2020 SC 13D/A
S-3 Jun 26, 2020 FORM S-3
S-8 Jun 26, 2020 S-8
8-K/A Jun 26, 2020 8-K/A
SC 13G Jun 11, 2020 SCHEDULE 13G
D Jun 10, 2020
D Jun 10, 2020
3 Jun 8, 2020
SC 13D Jun 8, 2020 SC 13D
SC 13D Jun 8, 2020
3 Jun 5, 2020 PRIMARY DOCUMENT
4 Jun 5, 2020 PRIMARY DOCUMENT
3 Jun 5, 2020 PRIMARY DOCUMENT
3 Jun 5, 2020 PRIMARY DOCUMENT
3 Jun 5, 2020 PRIMARY DOCUMENT
3 Jun 5, 2020 PRIMARY DOCUMENT
3 Jun 5, 2020 PRIMARY DOCUMENT
SC 13G/A Jun 5, 2020 AMENDMENT TO FORM SC 13G
8-K Jun 3, 2020 FORM 8-K
← Newer Page 13 of 28 · 696 filings Older →